Viemed Healthcare, Inc. (VMD)
USD 6.85
(-3.11%)
USD 6.85
(-3.11%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 5.97 Million USD | 2900.65% |
| 2022 | 199 Thousand USD | -95.65% |
| 2021 | 4.57 Million USD | -30.25% |
| 2020 | 6.55 Million USD | -38.53% |
| 2019 | 10.66 Million USD | 2607.61% |
| 2018 | 394 Thousand USD | -50.63% |
| 2017 | 798 Thousand USD | -69.67% |
| 2016 | 2.63 Million USD | 469.48% |
| 2015 | 462 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 8.03 Million USD | -1.6% |
| 2024 Q2 | 8.71 Million USD | 47.56% |
| 2023 Q2 | 12.4 Million USD | 7554.32% |
| 2023 Q3 | 8.49 Million USD | -31.53% |
| 2023 FY | 5.97 Million USD | 2900.65% |
| 2023 Q1 | 162 Thousand USD | -18.59% |
| 2023 Q4 | 5.97 Million USD | -29.67% |
| 2022 Q4 | 199 Thousand USD | -95.47% |
| 2022 FY | 199 Thousand USD | -95.65% |
| 2022 Q1 | 4.49 Million USD | -1.66% |
| 2022 Q2 | 4.43 Million USD | -1.45% |
| 2022 Q3 | 4.39 Million USD | -0.92% |
| 2021 Q3 | 5.18 Million USD | -9.74% |
| 2021 Q4 | 4.57 Million USD | -11.72% |
| 2021 FY | 4.57 Million USD | -30.25% |
| 2021 Q1 | 6.07 Million USD | -7.43% |
| 2021 Q2 | 5.74 Million USD | -5.45% |
| 2020 FY | 6.55 Million USD | -38.53% |
| 2020 Q4 | 6.55 Million USD | -9.08% |
| 2020 Q3 | 7.21 Million USD | -12.57% |
| 2020 Q2 | 8.25 Million USD | -13.24% |
| 2020 Q1 | 9.5 Million USD | -10.86% |
| 2019 Q1 | 1.18 Million USD | 201.52% |
| 2019 Q4 | 10.66 Million USD | -2.03% |
| 2019 Q2 | 5.8 Million USD | 388.3% |
| 2019 Q3 | 10.88 Million USD | 87.71% |
| 2019 FY | 10.66 Million USD | 2607.61% |
| 2018 Q2 | 1.04 Million USD | -19.82% |
| 2018 FY | 394 Thousand USD | -50.63% |
| 2018 Q1 | 1.3 Million USD | 63.78% |
| 2018 Q3 | 719 Thousand USD | -31.39% |
| 2018 Q4 | 394 Thousand USD | -45.2% |
| 2017 Q3 | 1.15 Million USD | 0.0% |
| 2017 Q1 | - USD | -100.0% |
| 2017 FY | 798 Thousand USD | -69.67% |
| 2017 Q4 | 798 Thousand USD | -30.61% |
| 2016 Q4 | 2.63 Million USD | 0.0% |
| 2016 FY | 2.63 Million USD | 469.48% |
| 2015 FY | 462 Thousand USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 83.46% |
| BrainsWay Ltd. | 239 Thousand USD | -2398.448% |
| Cerus Corporation | 59.79 Million USD | 90.014% |
| Envoy Medical, Inc. | 404 Thousand USD | -1378.042% |
| electroCore, Inc. | 537 Thousand USD | -1011.972% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -49660.758% |
| IceCure Medical Ltd | 376 Thousand USD | -1488.109% |
| Inogen, Inc. | 18.27 Million USD | 67.316% |
| OrthoPediatrics Corp. | 13.45 Million USD | 55.633% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -2900.649% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -1541.709% |
| MaxCyte, Inc. | 17.96 Million USD | 66.769% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -10701.12% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 93.587% |
| PAVmed Inc | 2.96 Million USD | -101.733% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 3.906% |
| RxSight, Inc. | 1.21 Million USD | -393.088% |
| Sight Sciences, Inc. | 31.7 Million USD | 81.168% |
| SI-BONE, Inc. | 36.06 Million USD | 83.443% |
| TELA Bio, Inc. | 40.51 Million USD | 85.262% |
| Treace Medical Concepts, Inc. | 53 Million USD | 88.735% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -292.59% |
| Acutus Medical, Inc. | 32.65 Million USD | 81.713% |
| Talis Biomedical Corporation | 16.78 Million USD | 64.427% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -47.622% |
| CVRx, Inc. | 30.38 Million USD | 80.346% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -487.188% |
| Bioventus Inc. | 366.99 Million USD | 98.373% |
| Venus Concept Inc. | 70.79 Million USD | 91.565% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -380.007% |
| LivaNova PLC | 568.54 Million USD | 98.95% |
| 908 Devices Inc. | 3.92 Million USD | -51.98% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 98.832% |
| Nemaura Medical Inc. | 3.08 Million USD | -93.393% |
| NeuroPace, Inc. | 56.95 Million USD | 89.516% |
| LENSAR, Inc. | 1.75 Million USD | -241.217% |
| Apyx Medical Corporation | 33.18 Million USD | 82.006% |
| Cutera, Inc. | 418.69 Million USD | 98.574% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 60.308% |
| BioSig Technologies, Inc. | 103 Thousand USD | -5697.37% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 77.805% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 39.981% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.598% |
| Axonics, Inc. | 25.84 Million USD | 76.891% |
| Outset Medical, Inc. | 134.59 Million USD | 95.564% |
| IRIDEX Corporation | 1.75 Million USD | -241.022% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 88.369% |
| IRadimed Corporation | 1.61 Million USD | -269.721% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -3292.779% |
| INVO Bioscience, Inc. | 6.77 Million USD | 11.877% |
| Telesis Bio, Inc. | 5.26 Million USD | -13.329% |
| Varex Imaging Corporation | 464.2 Million USD | 98.714% |
| Quipt Home Medical Corp. | 60.82 Million USD | 90.182% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -915.526% |
| Pulmonx Corporation | 35.08 Million USD | 82.982% |
| Dynatronics Corporation | 3.25 Million USD | -83.254% |
| Modular Medical, Inc. | 817 Thousand USD | -630.88% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -3854.497% |
| Semler Scientific, Inc. | 70 Thousand USD | -8430.416% |
| InMode Ltd. | 6.61 Million USD | 9.704% |
| Bruker Corporation | 1.14 Billion USD | 99.478% |
| Cytosorbents Corporation | 2.54 Million USD | -134.826% |
| DexCom, Inc. | 2.57 Billion USD | 99.768% |
| Align Technology, Inc. | 96.96 Million USD | 93.842% |
| Viveve Medical, Inc. | 5.12 Million USD | -16.536% |
| ZimVie Inc. | 508.79 Million USD | 98.826% |
| Movano Inc. | 15.00 USD | -39808506.667% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 67.055% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 98.502% |
| Profound Medical Corp. | 4.97 Million USD | -20.04% |
| Insulet Corporation | 1.36 Billion USD | 99.563% |
| enVVeno Medical Corporation | 1.06 Million USD | -461.212% |
| Surmodics, Inc. | 29.4 Million USD | 79.693% |
| iCAD, Inc. | 273 Thousand USD | -2087.286% |
| Nuwellis, Inc. | 221 Thousand USD | -2601.942% |
| Biotricity, Inc. | 10.85 Million USD | 44.995% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 82.915% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -819.012% |
| InspireMD, Inc. | 1.03 Million USD | -475.269% |
| PAVmed Inc. | 2.96 Million USD | -101.733% |
| BIOLASE, Inc. | 13.98 Million USD | 57.302% |
| Beyond Air, Inc. | 14.72 Million USD | 59.437% |
| FONAR Corporation | 37.92 Million USD | 84.257% |
| AxoGen, Inc. | 46.6 Million USD | 87.187% |
| Vivani Medical, Inc. | 19.31 Million USD | 69.081% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 86.615% |
| Inari Medical, Inc. | 30.35 Million USD | 80.328% |
| UFP Technologies, Inc. | 28 Million USD | 78.674% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -1275.731% |
| Tenon Medical, Inc. | 428 Thousand USD | -1295.161% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -495.937% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -177.453% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.715% |
| Sintx Technologies, Inc. | 3.68 Million USD | -61.955% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 83.958% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -915.526% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -901.894% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.331% |
| TransMedics Group, Inc. | 506.2 Million USD | 98.82% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -883.738% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -6356.497% |
| Hyperfine, Inc. | 64 Thousand USD | -9230.142% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 96.836% |
| Biomerica, Inc. | 459 Thousand USD | -1200.935% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -1228.48% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -3043.0% |
| Silk Road Medical, Inc | 75.62 Million USD | 92.104% |